Whether you are looking to incorporate a platform strategy or create a novel device, Insight can provide support and experience at every step
Insight is pleased to announce that we have been won a Red Dot Award: Design Concept 2017. This year’s entry, Skintact, creates a complete system to control and heal mild to severe eczema using medicated patches and light therapy.
Identifying, prioritizing and translating user needs into design guidance is critical to successfully developing a safe, effective and differentiated combination product that supports long term adherence.
Insight to showcase user needs poster at the 2017 Drug Delivery Partnership Conference Identifying, prioritizing and translating user needs into design guidance is critical to successfully developing a safe, effective and differentiated combination product that supports long term adherence. The process of interacting with users iteratively and frequently is the key to successful needs characterization.
ONdrugDelivery Magazine asks Insight partner, Mark Tunkel to share his insights on achieving differentiation in an increasingly competitive marketplace
From game changing advances in new diabetes therapies such as Sanofi’s inhaled insulin Afrezza to the expiration of blockbuster drug patents such as GSK’s Advair – the pulmonary space in pharmaceuticals has never been more dynamic. These current developments present both opportunities and challenges to pharmaceutical innovators and generics manufacturers alike. Here, Mark Tunkel, Partner & Business Development Director, Insight Product Development, explains how companies developing and marketing inhalable pharmaceuticals can explore other strategies to improve patient outcomes over and above what the drug and device can achieve, and thus differentiate their products.
Read the full article here: or – using the form below – contact us directly to learn how we can help with your product development pursuits.
Insight Product Development will be exhibiting at the PDA Universe of Pre-filled Syringes and Injection Devices on November 3 – 4th, 2015, in Vienna, Austria.
Insight thought leaders Craig Scherer, Co-founder and Senior Partner, and Mark Tunkel, Partner, will be on hand to discuss Insight’s device development expertise and perspective as outlined in our recent article, ‘Pushing Combination Product Risk Upstream to Accelerate Time to Market‘ featured in the PDA Letter, PDA’s membership magazine.
The Insight exhibit will be located at booth 138.
More about the conference:
The Universe of Pre-filled Syringes and Injection Devices covers all aspects of advancements in pharmaceutical science, technology and manufacturing of parenterals. It aims to provide the latest information on new materials, drugs and application systems in the interest of public health and to the benefit of patients and health care providers.
Learn more about Insight’s work in Pharmaceutical Delivery Devices.